Efficacy of Corticosteroids in Prevention of Fat Embolism Syndrome in Patients with Long Bone Fracture

Authors

  • Ali reza Saied
  • R.K. Scott
Abstract:

Fat embolism syndrome refers to a constellation of symptoms secondary to the presence of fat globules in the lung parenchyma and/or peripheral blood circulation. The syndrome is most often seen in association with long bone or pelvic fractures and can cause significant morbidity and mortality. The present randomized double blind placebo-controlled trial was conducted to evaluate the efficacy of prophylactic corticosteroids in the prevention of fat embolism syndrome and arterial hypoxia in patients with long bone fractures. Ninety-one patients with long bone fractures were randomized to case and control groups; 38 and 53 individuals, respectively. The patients in the case group received a single dose of 10 mg/kg intravenous methylprednisolone succinate upon presentation to the emergency room. The control group received placebo (normal saline). The primary endpoints evaluated were the presence of fat embolism syndrome, based on the Gurd criteria. Total two patients with fat embolism syndrome were observed in the corticosteroid-treated group (5/2%) compared with five patients in the control (9.4%; P=0.4). Arterial hypoxemia was observed in one patient in the corticosteroid-treated group (2/6%) versus eight patients in the control group (17/0%; P= 0.07). Mean arterial oxygen was not significantly different between the two groups (P=0.07). It seems that single dose methylprednisolone succinate (10 mg/kg intravenously) is not effective as prophylaxis for fat embolism syndrome and arterial hypoxemia.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

efficacy of corticosteroids in prevention of fat embolism syndrome in patients with long bone fracture

fat embolism syndrome refers to a constellation of symptoms secondary to the presence of fat globules in the lung parenchyma and/or peripheral blood circulation. the syndrome is most often seen in association with long bone or pelvic fractures and can cause significant morbidity and mortality. the present randomized double blind placebo-controlled trial was conducted to evaluate the efficacy of...

full text

Incidence of fat embolism syndrome in patients with long bone and/or pelvic fracture admitted to Shahid Bahonar hospital in Kerman

  this study was carried out from October 1993 through November 1995(26 months).during this period 3472 patients(2743 male and 729 female) with long bone and/or pelvic fracture were admitted in different wards of Shahid Bahonar hospital of Kerman.based on the Gurd criteria,25 of these patients (24 male,1 female) were suffering from fat embolism sundrome(FES).incidence of FES in this study was ...

full text

Do corticosteroids reduce the risk of fat embolism syndrome in patients with long-bone fractures? A meta-analysis.

BACKGROUND Fat embolism syndrome (FES) is a potentially lethal condition most commonly seen in polytrauma patients with multiple long-bone fractures. Treatment has centred around supportive care and early fracture fixation. Several small clinical trials have suggested corticosteroids benefit patients with FES, but this treatment remains controversial. Our objective was to determine the effect o...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 33  issue 4

pages  240- 243

publication date 2015-05-12

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023